Chemoinformaics analysis of ISODEXTROPIMARIC-ACID
Molecular Weight | 183.163 | nRot | 3 |
Heavy Atom Molecular Weight | 174.091 | nRig | 7 |
Exact Molecular Weight | 183.053 | nRing | 1 |
Solubility: LogS | -1.941 | nHRing | 1 |
Solubility: LogP | 1.145 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 23.6691 |
nHD | 2 | BPOL | 12.2029 |
QED | 0.511 |
Synth | 3.14 |
Natural Product Likeliness | 0.295 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.014 |
HIA | 0.01 |
CACO-2 | -5.593 |
MDCK | 0.0000029 |
BBB | 0.135 |
PPB | 0.850316 |
VDSS | 0.351 |
FU | 0.121244 |
CYP1A2-inh | 0.018 |
CYP1A2-sub | 0.11 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.046 |
CYP2c9-inh | 0.03 |
CYP2c9-sub | 0.404 |
CYP2d6-inh | 0.023 |
CYP2d6-sub | 0.164 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.045 |
CL | 3.93 |
T12 | 0.941 |
hERG | 0.003 |
Ames | 0.01 |
ROA | 0.735 |
SkinSen | 0.712 |
Carcinogencity | 0.18 |
EI | 0.847 |
Respiratory | 0.299 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.937985 |